annual CFF:
$260.58M+$256.12M(+5734.82%)Summary
- As of today (May 21, 2025), NVAX annual cash flow from financing activities is $260.58 million, with the most recent change of +$256.12 million (+5734.82%) on December 31, 2024.
- During the last 3 years, NVAX annual CFF has fallen by -$201.13 million (-43.56%).
- NVAX annual CFF is now -73.54% below its all-time high of $984.76 million, reached on December 31, 2020.
Performance
NVAX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$7.06M-$3.64M(-106.34%)Summary
- As of today (May 21, 2025), NVAX quarterly cash flow from financing activities is -$7.06 million, with the most recent change of -$3.64 million (-106.34%) on March 31, 2025.
- Over the past year, NVAX quarterly CFF has dropped by -$12.95 million (-219.96%).
- NVAX quarterly CFF is now -101.22% below its all-time high of $576.99 million, reached on March 31, 2021.
Performance
NVAX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$247.64M-$12.95M(-4.97%)Summary
- As of today (May 21, 2025), NVAX TTM cash flow from financing activities is $247.64 million, with the most recent change of -$12.95 million (-4.97%) on March 31, 2025.
- Over the past year, NVAX TTM CFF has dropped by -$117.09 million (-32.10%).
- NVAX TTM CFF is now -82.00% below its all-time high of $1.38 billion, reached on March 31, 2021.
Performance
NVAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVAX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5734.8% | -220.0% | -32.1% |
| 3 y3 years | -43.6% | -104.4% | +455.4% |
| 5 y5 years | +164.9% | -103.8% | +8.6% |
NVAX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.6% | +5734.8% | -102.7% | +98.0% | -55.9% | +230.8% |
| 5 y | 5-year | -73.5% | +5734.8% | -101.2% | +98.0% | -82.0% | +230.8% |
| alltime | all time | -73.5% | >+9999.0% | -101.2% | +98.0% | -82.0% | +230.8% |
NVAX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$7.06M(+106.3%) | $247.64M(-5.0%) |
| Dec 2024 | $260.58M(+5734.8%) | -$3.42M(+3427.8%) | $260.58M(-28.5%) |
| Sep 2024 | - | -$97.00K(-100.0%) | $364.39M(-35.1%) |
| Jun 2024 | - | $258.22M(+4287.0%) | $561.61M(+54.0%) |
| Mar 2024 | - | $5.89M(-94.1%) | $364.73M(+8066.8%) |
| Dec 2023 | $4.47M(-98.6%) | $100.39M(-49.1%) | $4.47M(-95.3%) |
| Sep 2023 | - | $197.12M(+221.4%) | $95.52M(-172.0%) |
| Jun 2023 | - | $61.34M(-117.3%) | -$132.58M(-29.9%) |
| Mar 2023 | - | -$354.38M(-285.1%) | -$189.26M(-158.2%) |
| Dec 2022 | $324.99M(-29.6%) | $191.44M(-718.0%) | $324.99M(+346.2%) |
| Sep 2022 | - | -$30.98M(-764.9%) | $72.84M(-17.3%) |
| Jun 2022 | - | $4.66M(-97.1%) | $88.09M(+97.6%) |
| Mar 2022 | - | $159.87M(-363.3%) | $44.59M(-90.3%) |
| Dec 2021 | $461.71M(-53.1%) | -$60.71M(+286.2%) | $461.71M(-50.2%) |
| Sep 2021 | - | -$15.72M(-59.5%) | $927.03M(+0.7%) |
| Jun 2021 | - | -$38.84M(-106.7%) | $920.37M(-33.1%) |
| Mar 2021 | - | $576.99M(+42.6%) | $1.38B(+39.7%) |
| Dec 2020 | $984.76M(+900.9%) | $404.61M(-1907.3%) | $984.76M(+61.4%) |
| Sep 2020 | - | -$22.39M(-105.4%) | $610.32M(-5.3%) |
| Jun 2020 | - | $416.62M(+124.1%) | $644.74M(+182.6%) |
| Mar 2020 | - | $185.92M(+516.2%) | $228.13M(+131.9%) |
| Dec 2019 | $98.38M(-4.3%) | $30.17M(+150.8%) | $98.38M(+36.5%) |
| Sep 2019 | - | $12.03M(>+9900.0%) | $72.07M(+18.0%) |
| Jun 2019 | - | $3000.00(-100.0%) | $61.06M(-46.9%) |
| Mar 2019 | - | $56.18M(+1356.6%) | $115.06M(+11.9%) |
| Dec 2018 | $102.81M(+59.3%) | $3.86M(+278.1%) | $102.81M(-11.7%) |
| Sep 2018 | - | $1.02M(-98.1%) | $116.36M(-16.3%) |
| Jun 2018 | - | $54.00M(+22.9%) | $138.97M(+49.3%) |
| Mar 2018 | - | $43.92M(+152.2%) | $93.10M(+44.3%) |
| Dec 2017 | $64.54M(-76.9%) | $17.41M(-26.3%) | $64.54M(+34.8%) |
| Sep 2017 | - | $23.63M(+190.6%) | $47.89M(+93.6%) |
| Jun 2017 | - | $8.13M(-47.1%) | $24.74M(+46.7%) |
| Mar 2017 | - | $15.36M(+1908.4%) | $16.86M(-94.0%) |
| Dec 2016 | $279.85M(+34.4%) | $765.00K(+59.4%) | $279.85M(+0.2%) |
| Sep 2016 | - | $480.00K(+89.7%) | $279.29M(-2.8%) |
| Jun 2016 | - | $253.00K(-99.9%) | $287.33M(-1.3%) |
| Mar 2016 | - | $278.35M(>+9900.0%) | $291.14M(+39.8%) |
| Dec 2015 | $208.28M(+89.8%) | $201.00K(-97.6%) | $208.28M(-0.0%) |
| Sep 2015 | - | $8.52M(+109.7%) | $208.35M(+4.0%) |
| Jun 2015 | - | $4.06M(-97.9%) | $200.41M(-34.1%) |
| Mar 2015 | - | $195.50M(>+9900.0%) | $304.04M(+177.1%) |
| Dec 2014 | $109.72M(-16.3%) | $268.00K(-53.9%) | $109.72M(+0.2%) |
| Sep 2014 | - | $581.00K(-99.5%) | $109.54M(-52.0%) |
| Jun 2014 | - | $107.70M(+9105.0%) | $228.33M(+82.6%) |
| Mar 2014 | - | $1.17M(+1171.7%) | $125.02M(-4.6%) |
| Dec 2013 | $131.03M(+143.6%) | $92.00K(-99.9%) | $131.03M(-17.1%) |
| Sep 2013 | - | $119.37M(+2618.5%) | $157.97M(+243.5%) |
| Jun 2013 | - | $4.39M(-38.9%) | $45.98M(-14.4%) |
| Mar 2013 | - | $7.18M(-73.4%) | $53.71M(-0.1%) |
| Dec 2012 | $53.79M(+383.3%) | $27.03M(+266.0%) | $53.79M(+88.0%) |
| Sep 2012 | - | $7.38M(-39.1%) | $28.61M(+29.2%) |
| Jun 2012 | - | $12.12M(+66.9%) | $22.15M(+30.0%) |
| Mar 2012 | - | $7.26M(+292.2%) | $17.04M(+53.1%) |
| Dec 2011 | $11.13M(-52.5%) | $1.85M(+100.5%) | $11.13M(+8.7%) |
| Sep 2011 | - | $923.00K(-86.8%) | $10.24M(-63.9%) |
| Jun 2011 | - | $7.00M(+417.5%) | $28.36M(+14.6%) |
| Mar 2011 | - | $1.35M(+41.2%) | $24.74M(+5.6%) |
| Dec 2010 | $23.43M | $958.00K(-95.0%) | $23.43M(-46.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $19.04M(+461.9%) | $43.50M(+30.3%) |
| Jun 2010 | - | $3.39M(+8818.4%) | $33.38M(-22.3%) |
| Mar 2010 | - | $38.00K(-99.8%) | $42.98M(+1.6%) |
| Dec 2009 | $42.29M(+148.9%) | $21.03M(+135.7%) | $42.29M(+97.3%) |
| Sep 2009 | - | $8.92M(-31.3%) | $21.43M(-28.6%) |
| Jun 2009 | - | $12.99M(-2098.6%) | $30.02M(+83.2%) |
| Mar 2009 | - | -$650.00K(-480.1%) | $16.39M(-3.6%) |
| Dec 2008 | $16.99M(-2460.0%) | $171.00K(-99.0%) | $16.99M(+4.5%) |
| Sep 2008 | - | $17.51M(-2806.6%) | $16.26M(-1468.9%) |
| Jun 2008 | - | -$647.00K(+1370.5%) | -$1.19M(-12.2%) |
| Mar 2008 | - | -$44.00K(-92.1%) | -$1.35M(+87.9%) |
| Dec 2007 | -$720.00K(-101.3%) | -$558.00K(-1014.8%) | -$720.00K(-248.1%) |
| Sep 2007 | - | $61.00K(-107.5%) | $486.00K(+224.0%) |
| Jun 2007 | - | -$812.00K(-237.9%) | $150.00K(-82.9%) |
| Mar 2007 | - | $589.00K(-9.1%) | $879.00K(-98.5%) |
| Dec 2006 | $56.89M(+184.6%) | $648.00K(-335.6%) | $56.89M(-22.6%) |
| Sep 2006 | - | -$275.00K(+231.3%) | $73.53M(-4.7%) |
| Jun 2006 | - | -$83.00K(-100.1%) | $77.12M(+0.3%) |
| Mar 2006 | - | $56.60M(+227.4%) | $76.90M(+284.7%) |
| Dec 2005 | $19.99M(-8.9%) | $17.29M(+421.7%) | $19.99M(+655.1%) |
| Sep 2005 | - | $3.31M(-1172.5%) | $2.65M(-87.8%) |
| Jun 2005 | - | -$309.00K(+0.7%) | $21.70M(-1.0%) |
| Mar 2005 | - | -$307.00K(+502.0%) | $21.91M(-0.2%) |
| Dec 2004 | $21.95M(-50.2%) | -$51.00K(-100.2%) | $21.95M(-54.1%) |
| Sep 2004 | - | $22.36M(<-9900.0%) | $47.81M(+87.6%) |
| Jun 2004 | - | -$94.00K(-65.2%) | $25.48M(-5.8%) |
| Mar 2004 | - | -$270.00K(-101.0%) | $27.04M(-38.7%) |
| Dec 2003 | $44.09M(+222.2%) | $25.81M(>+9900.0%) | $44.09M(+133.5%) |
| Sep 2003 | - | $41.00K(-97.2%) | $18.88M(+0.3%) |
| Jun 2003 | - | $1.47M(-91.3%) | $18.83M(-36.4%) |
| Mar 2003 | - | $16.78M(+2724.9%) | $29.59M(+116.2%) |
| Dec 2002 | $13.69M(-11.2%) | $594.00K(-7525.0%) | $13.69M(-0.7%) |
| Sep 2002 | - | -$8000.00(-100.1%) | $13.78M(-49.0%) |
| Jun 2002 | - | $12.22M(+1292.1%) | $27.02M(+73.1%) |
| Mar 2002 | - | $878.00K(+27.4%) | $15.61M(+1.3%) |
| Dec 2001 | $15.41M(-59.0%) | $689.00K(-94.8%) | $15.41M(-56.7%) |
| Sep 2001 | - | $13.23M(+1531.4%) | $35.58M(+54.3%) |
| Jun 2001 | - | $811.00K(+18.7%) | $23.05M(+3.4%) |
| Mar 2001 | - | $683.00K(-96.7%) | $22.30M(-40.6%) |
| Dec 2000 | $37.56M(+794.3%) | $20.85M(+2836.6%) | $37.56M(+123.4%) |
| Sep 2000 | - | $710.00K(+1167.9%) | $16.81M(+3.8%) |
| Jun 2000 | - | $56.00K(-99.6%) | $16.20M(-19.6%) |
| Mar 2000 | - | $15.94M(>+9900.0%) | $20.14M(+379.6%) |
| Dec 1999 | $4.20M(+250.0%) | $100.00K(0.0%) | $4.20M(-481.8%) |
| Sep 1999 | - | $100.00K(-97.5%) | -$1.10M(0.0%) |
| Jun 1999 | - | $4.00M(>+9900.0%) | -$1.10M(-77.6%) |
| Mar 1999 | - | $0.00(-100.0%) | -$4.90M(-508.3%) |
| Dec 1998 | $1.20M(-77.8%) | -$5.20M(-5300.0%) | $1.20M(-82.1%) |
| Sep 1998 | - | $100.00K(-50.0%) | $6.70M(+1.5%) |
| Jun 1998 | - | $200.00K(-96.7%) | $6.60M(+1.5%) |
| Mar 1998 | - | $6.10M(+1933.3%) | $6.50M(+20.4%) |
| Dec 1997 | $5.40M(+170.0%) | $300.00K(>+9900.0%) | $5.40M(-21.7%) |
| Sep 1997 | - | $0.00(-100.0%) | $6.90M(0.0%) |
| Jun 1997 | - | $100.00K(-98.0%) | $6.90M(0.0%) |
| Mar 1997 | - | $5.00M(+177.8%) | $6.90M(+245.0%) |
| Dec 1996 | $2.00M | $1.80M(>+9900.0%) | $2.00M(+900.0%) |
| Sep 1996 | - | $0.00(-100.0%) | $200.00K(0.0%) |
| Jun 1996 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is Novavax annual cash flow from financing activities?
- What is the all time high annual CFF for Novavax?
- What is Novavax annual CFF year-on-year change?
- What is Novavax quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Novavax?
- What is Novavax quarterly CFF year-on-year change?
- What is Novavax TTM cash flow from financing activities?
- What is the all time high TTM CFF for Novavax?
- What is Novavax TTM CFF year-on-year change?
What is Novavax annual cash flow from financing activities?
The current annual CFF of NVAX is $260.58M
What is the all time high annual CFF for Novavax?
Novavax all-time high annual cash flow from financing activities is $984.76M
What is Novavax annual CFF year-on-year change?
Over the past year, NVAX annual cash flow from financing activities has changed by +$256.12M (+5734.82%)
What is Novavax quarterly cash flow from financing activities?
The current quarterly CFF of NVAX is -$7.06M
What is the all time high quarterly CFF for Novavax?
Novavax all-time high quarterly cash flow from financing activities is $576.99M
What is Novavax quarterly CFF year-on-year change?
Over the past year, NVAX quarterly cash flow from financing activities has changed by -$12.95M (-219.96%)
What is Novavax TTM cash flow from financing activities?
The current TTM CFF of NVAX is $247.64M
What is the all time high TTM CFF for Novavax?
Novavax all-time high TTM cash flow from financing activities is $1.38B
What is Novavax TTM CFF year-on-year change?
Over the past year, NVAX TTM cash flow from financing activities has changed by -$117.09M (-32.10%)